The western region of Melbourne has one of the highest rates of diabetes mellitus in the country. One third of all inpatients of Western Health have diabetes, predominantly Type 2. Gestational diabetes is also very common affecting nearly 20 per cent of all pregnant women treated here. Western Health also cares for many people with Type 1 diabetes and unfortunately every year nearly 100 episodes of life-threatening diabetic ketoacidosis are managed in these patients. Our research activities focus therefore is predominantly on diabetes.

Current diabetes and endocrinology clinical trials 

C*STEROID trial substudy:  Maternal glycaemic responses to antenatal glucocorticoids in women without diabetes in pregnancy Investigator Initiated Sponsor:  University of Melbourne Principal Investigator:  Dr Annabel Jones

FAME1: The Fenofibrate And Microvascular Events in Type 1 diabetes (FAME 1) Eye Investigator Initiated Sponsor: University of Sydney Principal Investigators: A/Prof Shane Hamblin and Dr Dev Kevat

MOTHER app: Smartphone and Internet based interactive glucose management system for women with Diabetes in Pregnancy: Randomised Control Trial Investigator Initiated Sponsor:  Monash University Principal Investigator:  Dr Dev Kevat

POSSOM: Pregnancy outcomes of simplified screening versus standard 2-hour 75g-oral glucose tolerance test for diagnosis of gestational diabetes mellitus  – A Pilot Randomised Control Trial Investigator Initiated Sponsor: University of Melbourne Principal Investigator:  Dr I-Lynn Lee

PRECeDe substudy:  Maternal glycaemic response to antenatal glucocorticoids in women with diabetes in pregnancy Investigator Initiated Sponsor:  University of Melbourne Principal Investigator:  Dr Annabel Jones

PREDICT: Progression of Diabetic Complications Study Investigator Initiated Sponsor: Baker Heart and Diabetes Institute Principal Investigators: A/Prof Shane Hamblin and Dr Dev Kevat

RESTORE – ISI-ROM-001-2024:  A Prospective Investigation of the Feasibility and Safety of Duodenal Mucosal Regeneration for Type 2 Diabetes Mellitus Using Endoscopic Ablation Sponsor: Ascend Principal Investigators: Dr Alan Moss and Dr Dev Kevat

 

 

 

Page last updated December 2025